Cortisone is a hormone released by the adrenal gland in response to stress. It is a potent anti-inflammatory agent. Synthetically produced cortisone is more potent and longer acting than natural cortisone and is used for diagnosis as well as treatment of a variety of musculoskeletal conditions such as tendinopathy, bursitis and arthritis.
Artificial preparations containing cortisone are injected directly into the affected joint to relieve pain and reduce inflammation. Cortisone injections produce a significant reduction in pain and inflammation in a majority of cases. The duration and degree of the beneficial effect can vary from patient to patient. It takes about 2 to 3 days for the cortisone injection to produce any effect. In some individuals these injections may not produce any effect. The frequency of cortisone injections is limited by the risk of tendon rupture and damage to cartilage.
Cortisone injections offer significant relief in pain & inflammation however is associated with certain adverse effects. The most common side effect of cortisone injection is a “cortisone flare”, a condition where cortisone crystallizes in the injected area and causes severe pain. It usually occurs in the first 24-48 hours after the injection and lasts for a couple of days. It can be managed with the help of ice packs and analgesics. Other adverse effects associated with cortisone injection may include:
Viscosupplementation refers to the injection of a hyaluronan preparation into the joint. Hyaluronan is a natural substance present in the joint fluid that assists in lubrication. It allows smooth movement of the cartilage covered articulating surfaces of the joint.
Euflexxa is one of the most commonly used hyaluronan preparations. It is indicated in the management of shoulder, knee, hip or ankle osteoarthritis that has not responded to non-surgical treatment options such as pain medications, physical therapy and corticosteroid injections.
Euflexxa provides symptomatic relief and delays the need for surgery. It is injected directly into the joint to replenish the diminished synovial fluid, thereby enhancing its lubricating properties. A single dose or a total of three separate doses of Euflexxa, over several weeks, may be required for optimum benefit.
Some patients may experience mild pain, swelling, warmth and redness at the injection site for up to 48 hours following a Euflexxa injection. Headache and joint stiffness may also occur in some cases. Ice packs and an analgesic may be used, if required, to ease the discomfort. Any strenuous activity such as jogging or tennis should be completely avoided for 48 hours to a week after the injection and should be resumed only after consultation with your doctor.
Euflexxa injection not only supplements the hyaluronan in the joint but also stimulates the production of hyaluronan in the treated knee. This provides gradual symptomatic relief over the course of the injections. This effect may last for several months.
Please note: Immediately consult your doctor if you develop fever or the pain and swelling fail to resolve after 48 hours following the injection.